*Pseudomonas aeruginosa*, one of the most common and important nosocomial bacteria, often causes infections associated with blood, urinary tract, skin and soft tissue. The morbidity and mortality due to *P. aeruginosa* infections were very high among the severe patients, especially those in the intensive care unit wards.[@CIT0001] Carbapenems have been the most efficient antibiotics for treating multidrug-resistant *P. aeruginosa*. However, with the extensive use of carbapenem, the incidence of carbapenem-resistant *P. aeruginosa* increased significantly. In Zhejiang, China, the imipenem and meropenem resistance rates of *P. aeruginosa* had climbed up to 39.0% and 27%, respectively.[@CIT0002] Plasmid-mediated carbapenemase gene is most risky due to its potential to disseminate rapidly among different strains and species. *bla*~KPC-2~ gene was first discovered and also most prevalent in Hangzhou, China.[@CIT0003],[@CIT0004] Our previous study has reported that a KPC-2-producing *P. aeruginosa* clone (ST463) spread in Hangzhou, China.[@CIT0005] In this study, a *bla*~KPC-2~-bearing plasmid was isolated from *P. aeruginosa* ST463 strain PA1011 and sequenced. And then ,the genetic structure of the plasmid was analyzed.

Strain PA1011 was isolated from the sputum of a 58-year-old male inpatient with gastroesophageal variceal hemorrhage caused by liver cirrhosis, and was identified to be *P. aeruginosa* by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (Bruker Daltonik GmbH, Bremen, Germany). The patient was admitted to digestive department of the Second Affiliated Hospital of Zhejiang University, School of Medicine (Hangzhou, China) on October 2010, and then transferred to surgical intensive care unit. He had a surgery, followed by antimicrobial treatment and mechanical ventilation during hospitalization, and died after 20 days in hospital. Levofloxacin, imipenem and teicoplanin were used before strain PA1011 was isolated. The detailed antimicrobial treatment and bacterial isolation are described in [Figure 1](#F0001){ref-type="fig"}. Antimicrobial susceptibility test of PA1011 was performed by the micro-broth dilution method, and it was resistant to carbapenems, monobactams, fluoroquinolones, β-lactam combination agents, cephems, and only susceptible to lipopeptides and aminoglycosides. Figure 1Timeline of antimicrobial treatment and bacterial isolation of the patient. Colored text and bars represent the source that the bacterial species was isolated from.**Abbreviations:** CR, carbapenem-resistant; PA, *P. aeruginosa*; SM, *Stenotrophomonas maltophilia*; AB, *Acinetobacter baumannii*; CA, Candida albicans; LEV, levofloxacin; MEM, meropenem; TEC, teicoplanin; CIP, ciprofloxacin.

Plasmid DNA of PA1011 was extracted using the QIAGEN Plasmid Midi Prep kit according to the manufacturer's instructions (Valencia, CA, USA). Its sequence was determined using the Illumina NextSeq 500 (San Diego, CA, USA) and PacBio RSII (Pacific Biosciences) platforms. Raw PacBio reads were *de novo* assembled with SMRT analysis version 2.3 (HGAP3 algorithm) with default settings. The assembled sequence was corrected and polished with Illumina reads by Quiver v1, and closed with Circlator v. 1.5.1.[@CIT0006] The plasmid was annotated with the RAST tool (version 2.0)[@CIT0007] and Prokka (version 1.12.21).[@CIT0008] The plasmid incompatibility type was searched using the online tool PlasmidFinder (<https://cge.cbs.dtu.dk//services/PlasmidFinder/>). The annotated plasmid pPA1011 has been deposited in GenBank under accession number MH734334.

Plasmid pPA1011 was a 62,793 bp in length, encoding 185 predicted open reading frames (ORFs) with an average G+C content of 58.8%. pPA1011 contains a typical backbone structure, including regions involved in replication initiation (*repA*), partitioning (*parA*), plasmid maintenance, and type IV secretion (*vir* gene cluster), but it could not be assigned into any of known incompatibility groups. BLAST analysis showed that pPA1011 was overall similar to p14057 (accession number: KY296095)[@CIT0009] with 99% identity and 82% query coverage. p14057 was a 51.66 kb plasmid isolated from *P. aeruginosa* of human in Nanjing, China, which also carries *bla*~KPC-2~ gene ([Figure 2](#F0002){ref-type="fig"}). The major differences between p14057 and pPA1011 were a region encoding phage-related proteins and a region encoding hypothetical proteins on pPA1011. In addition, pPA1011 encodes multiple mobile genetic elements including an IS*Kpn27*, IS*Kpn6*, a copy of Tn*3*-like transposon and two copies of IS*26*.Figure 2Comparison of the genetic organization between pPA1011 and p14057. Genes are denoted by arrows. Shading denotes regions of homology (\>90% nucleotide identity). The accession number of p14057 for reference is KY296095.

KPC enzymes were detected most frequently in *K. pneumoniae* and other Enterobacteriaceae species in Hangzhou, China.[@CIT0010],[@CIT0011] Our previous study has first detected KPC enzymes in *P. aeruginosa* ST463. ST463 was a novel sequence type of KPC-producing *P. aeruginosa*, and only reported in Hangzhou, China. The genetic environment surrounding *bla*~KPC-2~ in pPA1011 was identical to pKP048 (accession number: FJ628167)[@CIT0012] from *K. pneumoniae* and the previously reported plasmid pE1 from *Escherichia coli*,[@CIT0013] with the ORFs organized as follows: Tn*3*-transposase, Tn*3*-resolvase, IS*Kpn8*, the *bla*~KPC-2~ gene, and IS*Kpn6* ([Figure 3](#F0003){ref-type="fig"}). It appeared to be a combination of a Tn*3*-based transposon and a partial Tn*4401* transposon. This genetic content (Tn*3*-IS*Kpn8-bla*~KPC-2~-IS*Kpn6*) of *bla*~KPC-2~ has been found among different enterobacterial species in the hospital.[@CIT0014] Notably, the *bla*~KPC-2~-bearing fragment was flanked by DIS*6* upstream and IS*26* downstream, which may have facilitated the spread of *bla*~KPC-2~ gene cassette in *P. aeruginosa* in Zhejiang, China. Figure 3Schematic representation of the genetic environment surrounding the *bla*~KPC-2~ gene on pPA1011. Genes and their corresponding transcription orientations are indicated by colored arrows. Shading denotes regions of homology (100% nucleotide identity). The accession numbers of pKP048, p14057 and Tn*4401* for reference are KT362706, KY296095 and FJ628167, respectively. The sequence of pE1 from Copyright©2014. American Society for Microbiology. Adapted from Cai JC, Zhang R, Hu YY, Zhou HW, Chen GX. Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China. Antimicrob Agents Chemother. 2014;58(2):1146--1152.[@CIT0013]

Conclusion {#S0002}
==========

This study presented the complete sequence of a novel plasmid pPA1011 in KPC-producing ST463 *P. aeruginosa*, an important nosocomial pathogen. The findings provided a deep insight into the mechanism of horizontal genetic transfer of *bla*~KPC-2~ in *P. aeruginosa*. pPA1011 carried a novel genetic environment of *bla*~KPC-2~ gene, which should be closely monitored to control the rapid spread of *bla*~KPC-2~ gene in *P. aeruginosa*.
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